- Consensus - lists.biobrillouin.org

Re: FW: [EXTERN] Your Nature Photonics paper – publication details-publication in Nature Photonics on 03 July 2025 at 16:00 (London time)
by Czarske, Juergen June 20, 2025

June 20, 2025

Publication in Nature Photonics on 03 July 2025 at 16:00 (London time) - Appreciate the great news!!! Many thanks are going especially to Kareem (was also great to meet you at the Light conference) Mit freundlichen Grüßen / Best regards, Juergen ------------------------------------------------------- Prof. Prof. h. c. Dr.-Ing. habil. Juergen Czarske Head of Laboratory of Measurement and Sensor Systems Director of Institute of Circuits and Systems Director of Competence Center Biomedical Computational Laser Systems (BIOLAS) TUD Dresden University of Technology Fakultät Elektrotechnik und Informationstechnik / Faculty of Electrical and Computer Engineering Institut für Grundlagen der Elektrotechnik und Elektronik / Institute of Circuits and Systems Competence Center Biomedical Computational Laser Systems Professur für Mess- und Sensorsystemtechnik / Chair of Measurement and Sensor Systems, Helmholtz Str. 18, 01062 Dresden, Germany Co-opted Professor of Physics, Institute of Applied Physics, TU Dresden Adjunct Professor of Optical Sciences, Wyant College, University of Arizona Tel.: +49 (351) 463-34803 Fax: +49 (351) 463-37716 E-Mail: juergen.czarske(a)tu-dresden.de Internet: http://www.lasermetrology.de https://tu-dresden.de/ing/elektrotechnik/iee/mst https://tu-dresden.de/ing/elektrotechnik/iee/mst/ressourcen/dateien/profess… Fellow OPTICA/OSA (The Optical Society, Washington, DC, USA) Fellow SPIE (The International Society for Optics and Photonics, Bellingham, WA, USA) Fellow EOS (European Optical Society, Joensuu, Finland) Fellow IET (Institution of Engineering and Technology, London, UK) Fellow IoP (Institute of Physics, London, UK) Elected Vice President of ICO (International Commission for Optics, Palaiseau/Paris, France & Miami, USA) https://quantum2025.org/iyq-event/from-classical-to-quantum-measurement-sys… Von: Kareem Elsayad <kareem.elsayad(a)meduniwien.ac.at> Datum: Freitag, 20. Juni 2025 um 01:07 An: "consensus(a)biobrillouin.org" <consensus(a)biobrillouin.org> Betreff: [Consensus Statement] FW: [EXTERN] Your Nature Photonics paper – publication details FYI From: Springer Nature <alerts(a)springernature.com> Reply to: <authorsupport(a)springernature.com> Date: Thursday, 19. June 2025 at 13:30 To: <F.Palombo(a)exeter.ac.uk>, <Bilenca(a)bgu.ac.il>, <Kareem.Elsayad(a)meduniwien.ac.at> Subject: [EXTERN] Your Nature Photonics paper – publication details Dear Author, Your paper, 'Consensus statement on Brillouin light scattering microscopy of biological materials', has been scheduled for publication in Nature Photonics on 03 July 2025 at 16:00 (London time), 03 July 2025 at 11:00 (US Eastern Time). The embargo will lift at this time. Please forward this information to any co-authors. You may also wish to make your media relations office aware of the forthcoming publication, in case they consider it appropriate to organize some internal or external publicity. The DOI number for your paper will be 10.1038/s41566-025-01681-6. Once your paper has been published online, it will be available at the following URL: https://www.nature.com/articles/s41566-025-01681-6 You are free to discuss your paper with the media, but we ask you to ensure that our embargo conditions (http://www.nature.com/authors/policies/embargo.html) are understood by journalists and others. Please do not post any press releases to the embargoed section of third-party internet journalist resource sites (such as EurekAlert or AlphaGalileo) more than 72 hours before publication. Journalists are permitted to show papers to independent specialists a few days in advance of publication, under embargo conditions, solely for the purpose of commenting on the work described. Journalists should credit Nature Photonics as the source of stories covered. If further clarification is required, please consult our embargo policy (http://www.nature.com/authors/policies/embargo.html) or contact press(a)nature.com. You can also find further information on the author information page of the Springer Nature press site: https://press.springernature.com/authors If you are reporting sequence or structural data with an accession code for a public database, we request you to set the release into the public domain upon receipt of this letter. This will allow our editors to test the link from the journal website to the database in readiness for the date of publication of your article. For authors reporting protein structures, release of the coordinates now will also allow us to set up a three-dimensional view window within the online version of the article. Please contact the editorial production department on rjsproduction(a)springernature.com if you have any queries. Sincerely Nature Photonics This is an automatically generated message. Replies are not monitored or answered.

1 0

FW: [EXTERN] Your Nature Photonics paper – publication details
by Kareem Elsayad June 19, 2025

June 19, 2025

FYI From: Springer Nature <alerts(a)springernature.com> Reply to: <authorsupport(a)springernature.com> Date: Thursday, 19. June 2025 at 13:30 To: <F.Palombo(a)exeter.ac.uk>, <Bilenca(a)bgu.ac.il>, <Kareem.Elsayad(a)meduniwien.ac.at> Subject: [EXTERN] Your Nature Photonics paper – publication details Dear Author, Your paper, 'Consensus statement on Brillouin light scattering microscopy of biological materials', has been scheduled for publication in Nature Photonics on 03 July 2025 at 16:00 (London time), 03 July 2025 at 11:00 (US Eastern Time). The embargo will lift at this time. Please forward this information to any co-authors. You may also wish to make your media relations office aware of the forthcoming publication, in case they consider it appropriate to organize some internal or external publicity. The DOI number for your paper will be 10.1038/s41566-025-01681-6. Once your paper has been published online, it will be available at the following URL: https://www.nature.com/articles/s41566-025-01681-6 You are free to discuss your paper with the media, but we ask you to ensure that our embargo conditions (http://www.nature.com/authors/policies/embargo.html) are understood by journalists and others. Please do not post any press releases to the embargoed section of third-party internet journalist resource sites (such as EurekAlert or AlphaGalileo) more than 72 hours before publication. Journalists are permitted to show papers to independent specialists a few days in advance of publication, under embargo conditions, solely for the purpose of commenting on the work described. Journalists should credit Nature Photonics as the source of stories covered. If further clarification is required, please consult our embargo policy (http://www.nature.com/authors/policies/embargo.html) or contact press(a)nature.com. You can also find further information on the author information page of the Springer Nature press site: https://press.springernature.com/authors If you are reporting sequence or structural data with an accession code for a public database, we request you to set the release into the public domain upon receipt of this letter. This will allow our editors to test the link from the journal website to the database in readiness for the date of publication of your article. For authors reporting protein structures, release of the coordinates now will also allow us to set up a three-dimensional view window within the online version of the article. Please contact the editorial production department on rjsproduction(a)springernature.com if you have any queries. Sincerely Nature Photonics This is an automatically generated message. Replies are not monitored or answered.

1 0

Re: affiliations and funding (timely)
by Czarske, Juergen May 10, 2025

May 10, 2025

Dear Kareem, appreciate the great success. Thanks. However, tiny changes should be done: OLD “Laboratory of Measurement and Sensor System Technique (MST) TU Dresden Dresden Germany” NEW ”Laboratory of Measurement and Sensor Systems (MST) and Competence Center Biomedical Computational Laser Systems (BIOLAS), Dresden University of Technology, Dresden, Germany” OLD ”J.C., N.K. and D.K. acknowledge funding from the DFG (grant number Cz55/44)” NEW ”J.C., N.K. and D.K. acknowledge funding from the DFG (grant numbers Cz55/44 and CZ 55/40-2)” Mit freundlichen Grüßen / Best regards, Juergen ------------------------------------------------------- Prof. Prof. h. c. Dr.-Ing. habil. Juergen Czarske Head of Laboratory of Measurement and Sensor Systems Director of Institute of Circuits and Systems Director of Competence Center Biomedical Computational Laser Systems (BIOLAS) TUD Dresden University of Technology Fakultät Elektrotechnik und Informationstechnik / Faculty of Electrical and Computer Engineering Institut für Grundlagen der Elektrotechnik und Elektronik / Institute of Circuits and Systems Competence Center Biomedical Computational Laser Systems Professur für Mess- und Sensorsystemtechnik / Chair of Measurement and Sensor Systems, Helmholtz Str. 18, 01062 Dresden, Germany Co-opted Professor of Physics, Institute of Applied Physics, TU Dresden Adjunct Professor of Optical Sciences, Wyant College, University of Arizona Tel.: +49 (351) 463-34803 Fax: +49 (351) 463-37716 E-Mail: juergen.czarske(a)tu-dresden.de Internet: http://www.lasermetrology.de https://tu-dresden.de/ing/elektrotechnik/iee/mst https://tu-dresden.de/ing/elektrotechnik/iee/mst/ressourcen/dateien/profess… Fellow OPTICA/OSA (The Optical Society, Washington, DC, USA) Fellow SPIE (The International Society for Optics and Photonics, Bellingham, WA, USA) Fellow EOS (European Optical Society, Joensuu, Finland) Fellow IET (Institution of Engineering and Technology, London, UK) Fellow IoP (Institute of Physics, London, UK) Elected Vice President of ICO (International Commission for Optics, Palaiseau/Paris, France & Miami, USA) https://quantum2025.org/iyq-event/from-classical-to-quantum-measurement-sys… Von: Kareem Elsayad <kareem.elsayad(a)meduniwien.ac.at> Datum: Samstag, 10. Mai 2025 um 03:10 An: "consensus(a)biobrillouin.org" <consensus(a)biobrillouin.org> Betreff: [Consensus Statement] affiliations and funding (timely) Hi All, This will hopefully be one of last emails to this “consensus” mailing list (maybe will send one more with link to article). But I need you to quickly and urgently check that your affiliations are all spelt out correct and your grants are all listed like you want them (note they do not want dashes (-) in these for whatever reason) before they start printing. For US, Canada, and Australia, they need state (or equivalent) also. For all others just city and country. I paste these below (for the grants you can hopefully find yourselves by initials). Please let me know by Sunday evening if you need any changes (sorry for short notice- they take 2 months and want us to do in two days!). Btw. our kind reviewers were Benjamin Eggleton, Kirill Larin and Fan Yang -- they chose to reveal themselves as is new journal thing -- so can thank them next time you bump into them 😊. Guess there wasn’t huge pool to choose from (I somehow expected at least one non-Brillouin/outsider person for context. Alas, suppose it’s all good and all’s well that ends well). All the best and talk soon! Kareem -- Division of Anatomy, Center for Anatomy & Cell Biology, Medical University of Vienna, Vienna, Austria Biology and Biophysics Unit European Molecular Biology Laboratory Heidelberg Germany Fischell Department of Bioengineering University of Maryland College Park MD USA Specto Srl Milan Italy CNR–Istituto Officina dei Materiali (IOM) Unità di Perugia Perugia Italy LightMachinery Inc Nepean Ontario Canada Department of Electronics Carleton University Ottawa Ontario Canada Laboratory of Measurement and Sensor System Technique (MST) TU Dresden Dresden Germany Cluster of Excellence Physics of Life TU Dresden Dresden Germany Competence Center for Biomedical Computational Laser Systems TU Dresden Dresden Germany Institut Lumière Matière, UMR5306 Université Lyon 1-CNRSUniversité de Lyon Lyon France Dipartimento di Fisica e Geologia Università di Perugia Perugia Italy Max Planck Institute for the Science of Light Erlangen Germany Department of Biology Norwegian University of Science and Technology Trondheim Norway Hannover Centre for Optical Technologies Leibniz University Hannover Hannover Germany CellSense Technologies GmbH Berlin Germany School of Mathematical and Physical Sciences University of Technology Sydney Sydney New South Wales Australia Department of Chemistry University of California Davis Davis CA USA Optics & Photonics Group, Faculty of Engineering University of Nottingham Nottingham UK Discipline of Mechanical, Manufacturing & Biomedical Engineering Trinity College Dublin Dublin Ireland Department of Bioengineering Imperial College London London UK CREST Optics S.p.A Rome Italy German Center for Lung Research (DZL) Heidelberg Germany Center for Life Nano- & Neuro-Science Istituto Italiano di Tecnologia Rome Italy The Table Stable Ltd Mettmenstetten Switzerland School of Physical & Mathematical Sciences Nanyang Technological University Singapore Singapore Lee Kong Chian School of Medicine, Singapore Centre of Environmental Life Sciences Engineering (SCELSE)Nanyang Technological University Singapore Singapore Institute for Digital Molecular Analytics & Sciences Nanyang Technological University Singapore Singapore Department of Biomedical Engineering Texas A&M University College Station TX USA Department of Electrical and Computer Engineering Texas A&M University College Station TX USA Department of Physics and Astronomy Texas A&M University College Station TX USA Harvard Medical School and Massachusetts General Hospital Boston MA USA Department of Biomedical Engineering Wayne State University Detroit MI USA Department of Biomedical Engineering and Institute for Quantitative Health Science & Engineering Michigan State University East Lansing MI USA Department of Physics and Astronomy University of Exeter Exeter UK Biomedical Engineering Department Ben-Gurion University of the Negev Beersheba Israel And acknowledgments… Acknowledgements: P.B. and K.E. acknowledge funding from the Austrian Science Fund, FWF (grant number P34783) and the Medical University of Vienna. C.B., J.L. and R.P. acknowledge funding from the EMBL, an ERC Consolidator Grant (grant number 864027, Brillouin4Life) and the German Center for Lung Research (DZL). S.C., D.F. and M. Mattarelli. AQ30acknowledge funding from the AQ31European Union - NextGenerationEU- (grant number ECS00000041, VITALITY, CUP J97G22000170005 and CUP B43C22000470005; Prin PNRR grant P2022RH4HH, COMBINE-CUP B53D2302864 0001 and PRIN 2022 CODIR, CUP J53D23001370006). J.C., N.K. and D.K. acknowledge funding from the DFG (grant number Cz55/44). D.H. and T.L. acknowledge funding from the DFG Cluster of Excellence PhoenixD (EXC 2122, grant number 390833453). H.J.-R. acknowledges funding from the Canada Research Chairs programme (grant numberCRC-2021-00456). I.K. acknowledges funding from the ARC Centre of Excellence in Quantum Technology (grant number CE230100021) and ARC Centre of Excellence in Optical Microcombs for Breakthrough Science (grant number CE230100006). K.K. acknowledges funding from the National Science Foundation (grant number DMR-2202472). S.L..C. III acknowledges funding from the Royal Academy of Engineering Research Fellowships scheme (grant number RF-2324-23-223) and Nottingham Research Fellowship scheme. J.M. acknowledges funding from an EIC-2022-PathfinderOpen grant (VIRUSong, grant number 101099058). M. Monegan. acknowledges funding from Research Ireland (grant number 13/RC/2073_P2) and Research Ireland Frontiers for the Future Project (grant number 22/FFP-P/11394). D.R.O. acknowledges funding from the National Institutes of Health (grant number EY022359). E.P. and C.T. acknowledge funding from an EIC-2022-PathfinderOpen grant (ivBM-4PAP, grant number 101098989). G.R. and C.T. acknowledge funding from an ERC-2019-Synergy Grant (ASTRA, grant number 855923). G.S. acknowledges funding from the National Science Foundation (grant number DBI-1942003) and the National Institutes of Health (grant numbers R21CA258008, R01EY028666, R01EY030063, R01EY032537 and R21EY035483). P.T. acknowledges funding from the Nanyang Technological University, the Ministry of Education (MOE) and the National Research Foundation (NRF). V.Y. acknowledges funding from The Air Force Office of Scientific Research 1189 (grant numbers FA9550-20-1-0366, FA9550-20-1-0367 and FA9550-23-1-0599), the National Institutes of Health (grant numbers R01GM127696, R01GM152633, R21GM142107 and 1R21CA269099) and support from NASA, BARDA, the NIH and USFDA under contract/agreement number 80ARC023CA002. S.H.-Y. acknowledges funding from the National Institutes of Health (grant numbers R01EY033356 and R01EY034857). J.Z. acknowledges funding from the National Science Foundation (grant number CBET-2339278) and National Institutes of Health (grant numbers K25HD097288 and R21HD112663). F.P. acknowledges funding from the UK Engineering and Physical Sciences Research Council (grant numbers EP/M028739/1 and NS/A000063/1) and Cancer Research UK (grant number /A000063/1). We acknowledge funding from the European Cooperation in Science and Technology (COST) Association (COST Action BioBrillouin grant number CA16124 and COST Innovators Grant BLiSS-BMD grant number IG16124).

1 0

affiliations and funding (timely)
by Kareem Elsayad May 10, 2025

May 10, 2025

Hi All, This will hopefully be one of last emails to this “consensus” mailing list (maybe will send one more with link to article). But I need you to quickly and urgently check that your affiliations are all spelt out correct and your grants are all listed like you want them (note they do not want dashes (-) in these for whatever reason) before they start printing. For US, Canada, and Australia, they need state (or equivalent) also. For all others just city and country. I paste these below (for the grants you can hopefully find yourselves by initials). Please let me know by Sunday evening if you need any changes (sorry for short notice- they take 2 months and want us to do in two days!). Btw. our kind reviewers were Benjamin Eggleton, Kirill Larin and Fan Yang -- they chose to reveal themselves as is new journal thing -- so can thank them next time you bump into them 😊. Guess there wasn’t huge pool to choose from (I somehow expected at least one non-Brillouin/outsider person for context. Alas, suppose it’s all good and all’s well that ends well). All the best and talk soon! Kareem -- Division of Anatomy, Center for Anatomy & Cell Biology, Medical University of Vienna, Vienna, Austria Biology and Biophysics Unit European Molecular Biology Laboratory Heidelberg Germany Fischell Department of Bioengineering University of Maryland College Park MD USA Specto Srl Milan Italy CNR–Istituto Officina dei Materiali (IOM) Unità di Perugia Perugia Italy LightMachinery Inc Nepean Ontario Canada Department of Electronics Carleton University Ottawa Ontario Canada Laboratory of Measurement and Sensor System Technique (MST) TU Dresden Dresden Germany Cluster of Excellence Physics of Life TU Dresden Dresden Germany Competence Center for Biomedical Computational Laser Systems TU Dresden Dresden Germany Institut Lumière Matière, UMR5306 Université Lyon 1-CNRSUniversité de Lyon Lyon France Dipartimento di Fisica e Geologia Università di Perugia Perugia Italy Max Planck Institute for the Science of Light Erlangen Germany Department of Biology Norwegian University of Science and Technology Trondheim Norway Hannover Centre for Optical Technologies Leibniz University Hannover Hannover Germany CellSense Technologies GmbH Berlin Germany School of Mathematical and Physical Sciences University of Technology Sydney Sydney New South Wales Australia Department of Chemistry University of California Davis Davis CA USA Optics & Photonics Group, Faculty of Engineering University of Nottingham Nottingham UK Discipline of Mechanical, Manufacturing & Biomedical Engineering Trinity College Dublin Dublin Ireland Department of Bioengineering Imperial College London London UK CREST Optics S.p.A Rome Italy German Center for Lung Research (DZL) Heidelberg Germany Center for Life Nano- & Neuro-Science Istituto Italiano di Tecnologia Rome Italy The Table Stable Ltd Mettmenstetten Switzerland School of Physical & Mathematical Sciences Nanyang Technological University Singapore Singapore Lee Kong Chian School of Medicine, Singapore Centre of Environmental Life Sciences Engineering (SCELSE)Nanyang Technological University Singapore Singapore Institute for Digital Molecular Analytics & Sciences Nanyang Technological University Singapore Singapore Department of Biomedical Engineering Texas A&M University College Station TX USA Department of Electrical and Computer Engineering Texas A&M University College Station TX USA Department of Physics and Astronomy Texas A&M University College Station TX USA Harvard Medical School and Massachusetts General Hospital Boston MA USA Department of Biomedical Engineering Wayne State University Detroit MI USA Department of Biomedical Engineering and Institute for Quantitative Health Science & Engineering Michigan State University East Lansing MI USA Department of Physics and Astronomy University of Exeter Exeter UK Biomedical Engineering Department Ben-Gurion University of the Negev Beersheba Israel And acknowledgments… Acknowledgements: P.B. and K.E. acknowledge funding from the Austrian Science Fund, FWF (grant number P34783) and the Medical University of Vienna. C.B., J.L. and R.P. acknowledge funding from the EMBL, an ERC Consolidator Grant (grant number 864027, Brillouin4Life) and the German Center for Lung Research (DZL). S.C., D.F. and M. Mattarelli. AQ30acknowledge funding from the AQ31European Union - NextGenerationEU- (grant number ECS00000041, VITALITY, CUP J97G22000170005 and CUP B43C22000470005; Prin PNRR grant P2022RH4HH, COMBINE-CUP B53D2302864 0001 and PRIN 2022 CODIR, CUP J53D23001370006). J.C., N.K. and D.K. acknowledge funding from the DFG (grant number Cz55/44). D.H. and T.L. acknowledge funding from the DFG Cluster of Excellence PhoenixD (EXC 2122, grant number 390833453). H.J.-R. acknowledges funding from the Canada Research Chairs programme (grant numberCRC-2021-00456). I.K. acknowledges funding from the ARC Centre of Excellence in Quantum Technology (grant number CE230100021) and ARC Centre of Excellence in Optical Microcombs for Breakthrough Science (grant number CE230100006). K.K. acknowledges funding from the National Science Foundation (grant number DMR-2202472). S.L..C. III acknowledges funding from the Royal Academy of Engineering Research Fellowships scheme (grant number RF-2324-23-223) and Nottingham Research Fellowship scheme. J.M. acknowledges funding from an EIC-2022-PathfinderOpen grant (VIRUSong, grant number 101099058). M. Monegan. acknowledges funding from Research Ireland (grant number 13/RC/2073_P2) and Research Ireland Frontiers for the Future Project (grant number 22/FFP-P/11394). D.R.O. acknowledges funding from the National Institutes of Health (grant number EY022359). E.P. and C.T. acknowledge funding from an EIC-2022-PathfinderOpen grant (ivBM-4PAP, grant number 101098989). G.R. and C.T. acknowledge funding from an ERC-2019-Synergy Grant (ASTRA, grant number 855923). G.S. acknowledges funding from the National Science Foundation (grant number DBI-1942003) and the National Institutes of Health (grant numbers R21CA258008, R01EY028666, R01EY030063, R01EY032537 and R21EY035483). P.T. acknowledges funding from the Nanyang Technological University, the Ministry of Education (MOE) and the National Research Foundation (NRF). V.Y. acknowledges funding from The Air Force Office of Scientific Research 1189 (grant numbers FA9550-20-1-0366, FA9550-20-1-0367 and FA9550-23-1-0599), the National Institutes of Health (grant numbers R01GM127696, R01GM152633, R21GM142107 and 1R21CA269099) and support from NASA, BARDA, the NIH and USFDA under contract/agreement number 80ARC023CA002. S.H.-Y. acknowledges funding from the National Institutes of Health (grant numbers R01EY033356 and R01EY034857). J.Z. acknowledges funding from the National Science Foundation (grant number CBET-2339278) and National Institutes of Health (grant numbers K25HD097288 and R21HD112663). F.P. acknowledges funding from the UK Engineering and Physical Sciences Research Council (grant numbers EP/M028739/1 and NS/A000063/1) and Cancer Research UK (grant number /A000063/1). We acknowledge funding from the European Cooperation in Science and Technology (COST) Association (COST Action BioBrillouin grant number CA16124 and COST Innovators Grant BLiSS-BMD grant number IG16124).

2 1

FW: [EXTERN] Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B
by Kareem Elsayad April 24, 2025

April 24, 2025

fyi They mention (as per template) can propose cover image – if anyone feels inclined to make or has on hand pretty pic in their desired futuristic-photonics-style that they would like to see on glossy magazine cover just let me know & can forward/propose. All the best, Kareem From: <giampaolo.pitruzzello(a)nature.com> Reply to: <giampaolo.pitruzzello(a)nature.com> Date: Wednesday, 16. April 2025 at 00:52 To: <kareem.elsayad(a)meduniwien.ac.at> Subject: [EXTERN] Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B 15th April 2025 Dear Kareem, All your hard work has paid off and I am delighted to inform you that your manuscript, "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials", has now been formally accepted for publication in Nature Photonics. Congratulations! It's been a long journey and I am so glad to see this piece now finalised. I do think it will be a valuable resource for the Brillouin community. Before your manuscript is typeset, we will edit the text to ensure that your findings are clear to our wide readership and that the paper conforms with Nature Photonics style. We look particularly carefully at the titles of all papers to ensure that they are concise and clear. Once your manuscript is typeset and you have completed the appropriate grant of rights, you will receive a link to your electronic proof via email with a request to make any corrections within 48 hours. If, when you receive your proof, you cannot meet this deadline, please inform us at rjsproduction(a)springernature.com immediately. You may wish to make your media relations office aware of your accepted publication, in case they consider it appropriate to organize some internal or external publicity. Once your paper has been scheduled you will receive an email confirming the publication details. This is normally 3-4 working days in advance of publication. If you need additional notice of the date and time of publication, please let the production team know when you receive the proof of your article to ensure there is sufficient time to coordinate. Further information on our embargo policies can be found here: https://www.nature.com/authors/policies/embargo.html Acceptance of your manuscript is conditional upon all authors' agreement with our publication policies (see http://www.nature.com/nphoton/authors/index.html#publishing-policies) In particular, your manuscript must not be published elsewhere and there must be no announcement of the work to any media outlet until the publication date (the day on which it is uploaded onto our website). Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal’s standard licensing terms will need to be accepted, including self-archiving policies. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript. An online order form for reprints of your paper is available at https://www.nature.com/reprints/author-reprints.html. All co-authors, authors' institutions and authors' funding agencies can order reprints using the form appropriate to their geographical region. We welcome the submission of potential cover material (including a short caption of around 40 words) related to your manuscript; suggestions should be sent as electronic image files (the image should be 300 dpi at 210 x 297 mm in either TIFF or JPEG format). You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals. To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides you with a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF. In approximately 10 business days you will receive an email with a link to choose the appropriate publishing options for your paper and our Author Services team will be in touch regarding any additional information that may be required. If you have any questions about our publishing options, costs, Open Access requirements, or our legal forms, please contact ASJournals(a)springernature.com As soon as your article is published, you will receive an automated email with your shareable link. Lastly, I would like to personally thank you for choosing Nature Photonics as the journal in which to disseminate your exciting research. It has been a pleasure working with you. We would welcome submissions reporting important findings from you in the future. With kind regards, Dr Giampaolo Pitruzzello Senior Editor Nature Photonics ** Visit the Springer Nature Editorial and Publishing website at www.springernature.com/editorial-and-publishing-jobs for more information about our career opportunities. If you have any questions please click here.** This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS Confidentiality Statement: This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com . Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html Privacy Policy | Update Profile

4 4

GOOD NEWS NPHOT-2024-04-00624B
by Czarske, Juergen April 16, 2025

April 16, 2025

Congratulations Appreciate the fantastic news Thank you for your successful work, especially of Kareem Mit freundlichen Grüßen / Best regards, Juergen ------------------------------------------------------- Prof. Prof. h. c. Dr.-Ing. habil. Juergen Czarske Head of Laboratory of Measurement and Sensor Systems Director of Institute of Circuits and Systems Director of Competence Center Biomedical Computational Laser Systems (BIOLAS) TUD Dresden University of Technology Fakultät Elektrotechnik und Informationstechnik / Faculty of Electrical and Computer Engineering Institut für Grundlagen der Elektrotechnik und Elektronik / Institute of Circuits and Systems Competence Center Biomedical Computational Laser Systems Professur für Mess- und Sensorsystemtechnik / Chair of Measurement and Sensor Systems, Helmholtz Str. 18, 01062 Dresden, Germany Co-opted Professor of Physics, Institute of Applied Physics, TU Dresden Adjunct Professor of Optical Sciences, Wyant College, University of Arizona Tel.: +49 (351) 463-34803 Fax: +49 (351) 463-37716 E-Mail: juergen.czarske(a)tu-dresden.de Internet: http://www.lasermetrology.de https://tu-dresden.de/ing/elektrotechnik/iee/mst https://tu-dresden.de/ing/elektrotechnik/iee/mst/ressourcen/dateien/profess… Fellow OPTICA/OSA (The Optical Society, Washington, DC, USA) Fellow SPIE (The International Society for Optics and Photonics, Bellingham, WA, USA) Fellow EOS (European Optical Society, Joensuu, Finland) Fellow IET (Institution of Engineering and Technology, London, UK) Fellow IoP (Institute of Physics, London, UK) Elected Vice President of ICO (International Commission for Optics, Palaiseau/Paris, France & Miami, USA) https://quantum2025.org/iyq-event/from-classical-to-quantum-measurement-sys… https://www.quantum2025.de/veranstaltungen/classical-quantum-measurement-sy… Von: "giampaolo.pitruzzello(a)nature.com" <giampaolo.pitruzzello(a)nature.com> Antworten an: "giampaolo.pitruzzello(a)nature.com" <giampaolo.pitruzzello(a)nature.com> Datum: Mittwoch, 16. April 2025 um 00:52 An: "Czarske, Jürgen" <juergen.czarske(a)tu-dresden.de> Betreff: Final Decision made for NPHOT-2024-04-00624B Dear Professor Czarske, Please find below a copy of the decision letter for your manuscript "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" [NPHOT-2024-04-00624B], which has just been accepted for publication in Nature Photonics. You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals. To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides all co-authors with the ability to generate a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF. As soon as your article is published, you can generate your shareable link by entering the DOI of your article here: http://authors.springernature.com/share. Corresponding authors will also receive an automated email with the shareable link. Sincerely, Dr Giampaolo Pitruzzello Senior Editor Nature Photonics ------------------------------------------------------------------------ Subject: Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B 15th April 2025 Dear Kareem, All your hard work has paid off and I am delighted to inform you that your manuscript, "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials", has now been formally accepted for publication in Nature Photonics. Congratulations! It's been a long journey and I am so glad to see this piece now finalised. I do think it will be a valuable resource for the Brillouin community. Before your manuscript is typeset, we will edit the text to ensure that your findings are clear to our wide readership and that the paper conforms with Nature Photonics style. We look particularly carefully at the titles of all papers to ensure that they are concise and clear. Once your manuscript is typeset and you have completed the appropriate grant of rights, you will receive a link to your electronic proof via email with a request to make any corrections within 48 hours. If, when you receive your proof, you cannot meet this deadline, please inform us at rjsproduction(a)springernature.com immediately. You may wish to make your media relations office aware of your accepted publication, in case they consider it appropriate to organize some internal or external publicity. Once your paper has been scheduled you will receive an email confirming the publication details. This is normally 3-4 working days in advance of publication. If you need additional notice of the date and time of publication, please let the production team know when you receive the proof of your article to ensure there is sufficient time to coordinate. Further information on our embargo policies can be found here: https://www.nature.com/authors/policies/embargo.html Acceptance of your manuscript is conditional upon all authors' agreement with our publication policies (see http://www.nature.com/nphoton/authors/index.html#publishing-policies) In particular, your manuscript must not be published elsewhere and there must be no announcement of the work to any media outlet until the publication date (the day on which it is uploaded onto our website). Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal’s standard licensing terms will need to be accepted, including self-archiving policies. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript. An online order form for reprints of your paper is available at https://www.nature.com/reprints/author-reprints.html. All co-authors, authors' institutions and authors' funding agencies can order reprints using the form appropriate to their geographical region. We welcome the submission of potential cover material (including a short caption of around 40 words) related to your manuscript; suggestions should be sent as electronic image files (the image should be 300 dpi at 210 x 297 mm in either TIFF or JPEG format). You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals. To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides you with a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF. In approximately 10 business days you will receive an email with a link to choose the appropriate publishing options for your paper and our Author Services team will be in touch regarding any additional information that may be required. If you have any questions about our publishing options, costs, Open Access requirements, or our legal forms, please contact ASJournals(a)springernature.com As soon as your article is published, you will receive an automated email with your shareable link. Lastly, I would like to personally thank you for choosing Nature Photonics as the journal in which to disseminate your exciting research. It has been a pleasure working with you. We would welcome submissions reporting important findings from you in the future. With kind regards, Dr Giampaolo Pitruzzello Senior Editor Nature Photonics ** Visit the Springer Nature Editorial and Publishing website at www.springernature.com/editorial-and-publishing-jobs for more information about our career opportunities. If you have any questions please click here.** This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS Confidentiality Statement: This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com . Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html Privacy Policy | Update Profile

1 0

FW: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A
by Kareem Elsayad Feb. 26, 2025

Feb. 26, 2025

Hi All, Just quick update I got & wanted to share 😊 Should be able to deal with this without your help -- only formatting stuff (but will contact you individually if/as needed). Will keep you posted, and I guess you will get some form of confirmation when uploaded again. Thanks again for being part of this & see you latest (hopefully) in Boston! All the best, Kareem From: <giampaolo.pitruzzello(a)nature.com> Reply to: <giampaolo.pitruzzello(a)nature.com> Date: Wednesday, 26. February 2025 at 03:30 To: <kareem.elsayad(a)meduniwien.ac.at> Subject: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A 25th February 2025 * Please ensure you delete the link to your author homepage in this e-mail if you wish to forward it to your co-authors. Dear Kareem, I have some good news. Your revised Consensus Statement article entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" has now been seen by the original referees #1 and #2, and their comments are included below. In light of their advice, I am delighted to say that we can now in principle offer to publish it, provided that you revise the paper to format it in accordance with our needs described below. Our format requirements are explained in full at www.nature.com/nphoton/authors/index.html. 1. Title. To avoid unwieldy titles, we ask that you use no more than 15 words, and no punctuation. I believe that the current title is sufficiently clear and concise and that no further changes are needed. 2. Headings. I think that the current headings are suitable and suggest no changes are made. 3. Abstract. The abstract should serve as a general introduction to the topic, underlining the importance and relevance of a particular area, and as a brief guide to the coverage of the Consensus Statement article. Because we hope that scientists in a wide range of research areas will be interested in our articles, the abstract should be as accessible as possible, explaining essential but specialised terms concisely. We encourage you to show your abstract to colleagues in other fields to uncover any problematic concepts. This paragraph must contain no more than 120 words and should not include references. I suggest the version below which has been edited for reasons of length and clarity: Brillouin Light Scattering (BLS) spectroscopy is a non-invasive, non-contact, label-free optical technique that can provide information on the mechanical properties of a material on the sub-micron scale. Over the last decade, BLS has seen increased applications in the life sciences, driven by the observed significance of mechanical properties in biological processes, the realization of more sensitive BLS spectrometers and the extension of BLS to an imaging modality. As with other spectroscopic techniques, BLS measurements not only detect signals characteristic of the investigated sample, but also of the experimental apparatus, and can be significantly affected by measurement conditions. Here, we report a consensus between researchers in the field. We aim to improve the comparability of BLS studies by providing reporting recommendations for the measured parameters and detailing common artifacts. Given that most BLS studies of biological matter are still at proof-of-concept stages and use different, often self-built, spectrometers, a consensus statement is particularly timely to ensure unified advancement. 4. Main text. Please take care to ensure that the length does not exceed 6000 words To ensure that a Consensus Statement article is likely to be accessible to as many readers as possible, it may be useful to ask a colleague from another discipline to read the manuscript before resubmitting it. ** Please ensure that all acronyms and symbols in equations are defined when first introduced. ** Please use UK English throughout. ** Please use a plain black font with no high highlighting or underlining. ** Please remove all figures from the main text and supply them as separate files. 5. Figures. A Consensus Statement typically contains 4-6 display items (figures, tables and boxes) and these should be supplied separately from the main text. *** Please ensure that all figures have scale bars as appropriate. *** Please ensure that all axes of graphs are labelled clearly and supplied with units. If your figures contain several parts, the parts should be labelled lower case a, b, and so on, and form a neat rectangle when assembled. For detailed instructions, please see our Guide for Authors at https://www.nature.com/documents/NRJs-guide-to-preparing-final-artwork.pdf If you have reproduced or adapted figure from other venues, please provide us full details of the figures so that we can approach the relevant authors for high-resolution files and the relevant publishers for figure permissions. The form can be found here: http://www.nature.com/documents/thirdpartyrights-table.doc If the figures come from your group, please provide us their high-resolution files. Below are some of the guidelines. For more details, please refer to the digital figure guidelines at the end of this email. Figure files must be supplied at an appropriate resolution for print publication. Colour: 300 dpi minimum; please convert all colour files into CMYK mode. Greyscale: 600 dpi minimum for black-and-white photographs. Line art: 1,200 dpi minimum for graphs and illustrations. Please do not scan laser printouts of figures and send them to us as digital files. The dot pattern on a laser print often creates a moire pattern when scanned. 6. Figure captions. Each caption should start with a brief introductory sentence to describe the figure as a whole, before going on to describe each panel of the figure (labelled a, b, c, etc.) in more detail, including any symbols that are used. The caption for each figure should not exceed 150 words. 7. References. ** As a guideline, a Consensus Statement allows up to ~ 100 references. ** Please check that your formatting is correct. Please note that Nature Photonics adopts the standard Nature referencing style, i.e. - All authors should be included in reference lists unless there are more than five, in which case only the first author should be given, followed by 'et al.'. Authors should be listed last name first, followed by a comma and initials of given names. There should be no spaces between initials. Article titles should be in Roman text and book titles in italics; the first word of the title is capitalized, the title written exactly as it appears in the work cited, ending with a full stop. Journal names are italicized and abbreviated (with full stops) according to common usage; please refer to Index Medicus for details. Volume numbers should appear in bold. Please correct the format of your references as necessary. References are numbered sequentially as they appear in the text, tables and figure legends. We only allow one publication is given for each reference number. Only papers that have been published or accepted by a named publication should appear in the numbered list; preprints of accepted papers in the reference list should be submitted with the manuscript. Meeting abstracts and submitted manuscripts should be mentioned in the text with a list of authors (or initials if any of the authors are co-authors of the present contribution). Authors should avoid excessive use of "unpublished results". Published conference abstracts and URLs for web sites should be cited parenthetically in the text, not in the reference list. Grant details and acknowledgements are not permitted as numbered references. Footnotes are not used. 8. Acknowledgements. These should appear after the references at the end of the manuscript. Please keep them brief; professional titles and affiliations are unnecessary. Grant numbers may be included. 9. Materials & Correspondence. Please include a statement naming the author to whom correspondence and requests for materials should be addressed. 10. Manuscript file format. *** When uploading the final version of your manuscript please be sure to include a MS Word .doc format of the main text (our production department handling Reviews/Perspectives/Consensus Statement manuscripts can not process LaTeX, .pdf etc). We will not send your revised paper for further review if, in the editors' judgement, the referees' comments on the present version have been fully addressed. If the revised paper is in Nature Photonics format, in accessible style and of appropriate length, we shall accept it for publication immediately. 11. Competing Interests In the interests of transparency, Nature and the Nature Portfolio journals now require authors of most article types to declare any financial and non-financial competing interest. Therefore, on behalf of all authors, we ask that you take particular care to declare any competing interests when submitting your Comment in the Manuscript Tracking System, under the “Detailed Information” tab of “Manuscript Information”. Please also add a competing interests declaration to your article file (if you do not have any competing interests, please include the statement “The authors declare no competing interests”). The competing interests statement will be published with the final article. For more information please see our Competing Interests policy page 12. ORCID Nature Photonics is committed to improving transparency in authorship. As part of our efforts in this direction, we are now requesting that all authors identified as ‘corresponding author’ create and link their Open Researcher and Contributor Identifier (ORCID) with their account on the Manuscript Tracking System (MTS) prior to acceptance. ORCID helps the scientific community achieve unambiguous attribution of all scholarly contributions. For more information please visit http://www.springernature.com/orcid For all corresponding authors listed on the manuscript, please follow the instructions in the link below to link your ORCID to your account on our MTS before submitting the final version of the manuscript. If you do not yet have an ORCID you will be able to create one in minutes. https://www.springernature.com/gp/researchers/orcid/orcid-for-nature-resear… IMPORTANT: All authors identified as ‘corresponding author’ on the manuscript must follow these instructions. Non-corresponding authors do not have to link their ORCIDs but are encouraged to do so. Please note that it will not be possible to add/modify ORCIDs at proof. Thus, if they wish to have their ORCID added to the paper they must also follow the above procedure prior to acceptance. To support ORCID's aims, we only allow a single ORCID identifier to be attached to one account. If you have any issues attaching an ORCID identifier to your MTS account, please contact the http://platformsupport.nature.com/"">Platform Support Helpdesk. 13. CONSORTIA AUTHORSHIP For papers containing one or more consortia, all members of the consortium who contributed to the paper must be listed in the paper (i.e., print/online PDF). If necessary, individual authors can be listed in both the main author list and as a member of a consortium listed at the end of the paper. When submitting your revised manuscript via the online submission system, the consortium name should be entered as an author, together with the contact details of a nominated consortium representative. See https://www.nature.com/authors/policies/authorship.html for our authorship policy and https://www.nature.com/documents/nr-consortia-formatting.pdf for further consortia formatting guidelines, which should be adhered to prior to acceptance. Before we can proceed with final acceptance of your manuscript, you will need to submit a final version of the revised manuscript text and all publication quality figures (if the figures are from your group), together with a point-by-point response to all of the referees' concerns, as well as our editorial requests. Please use the following link to do this: LINK I SHOULD DELETE * This URL links to your confidential homepage and associated information about manuscripts you may have submitted or be reviewing for us. If you wish to forward this e-mail to co-authors, please delete this link to your homepage first. Nature Photonics has now transitioned to a unified Rights Collection system which will allow our Author Services team to quickly and easily collect the rights and permissions required to publish your work. Once your paper is accepted, you will receive an email in approximately 10 business days providing you with a link to complete the grant of rights. Please note that you will not receive your proofs until the publishing agreement has been received through our system. If you have any questions please contact ASJournals(a)springernature.com. * Suggestions for cover illustrations, which should be provided as high resolution electronic files, are welcome. Please note that such pictures should be selected more for their aesthetic appeal than for their scientific content. As I am sure you will understand, we cannot make any promise as to whether any of your suggestions might be selected for the cover of Nature Photonics. Carefully following the guidelines outlined above, as well as those listed in the Nature Photonics Guide to Authors (www.nature.com/nphoton/authors/index.html) will eliminate any unnecessary delays in the processing of your manuscript once it is formally accepted. ** We hope to hear from you within three weeks; please let us know if the revision process is likely to take longer. In recognition of the time and expertise our reviewers provide to Nature Photonics’s editorial process, we would like to formally acknowledge their contribution to the external peer review of your manuscript entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials". For those reviewers who give their assent, we will be publishing their names alongside the published article. We will not be publishing any of the submitted peer review comments. And finally, you may be aware that Nature Photonics encourages the posting of submitted manuscripts on the preprint server, www.arxiv.org. We do, however, ask you to respect our policy on the posting of particular versions of the manuscript, summarized as follows: 1. You are welcome to post the original submitted version of the manuscript at any time. 2. The accepted version of the manuscript, following the review process, may only be posted 6 months after the paper is published in Nature Photonics. 3. The published version - copyedited and in Nature Photonics format - may not be posted in the arxiv or on authors' websites. Best wishes, Dr Giampaolo Pitruzzello Senior Editor Nature Photonics ***************************************************** Please see our Guide to Preparing Final Artwork here: https://www.nature.com/documents/NRJs-guide-to-preparing-final-artwork.pdf for detailed instructions of how to format your figures. Reviewers’ Comments: -------------------- Reviewer #1 (Remarks to the Author): The authors have thoroughly addressed all my concerns, and I have no additional comments. I fully support the publication of this manuscript without delay. Reviewer #2 (Remarks to the Author): The authors addressed my previous comments satisfactorily, and I recommend that the manuscript be accepted for publication in its current form. ***************************************************** This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS Confidentiality Statement: This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com . Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html Privacy Policy | Update Profile

8 7

Re: FW: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A
by Czarske, Juergen Feb. 26, 2025

Feb. 26, 2025

Hurray, Now we should drink a glass of champagne today. I'll drink at least two, as we're also celebrating a promotion today. Really great news „I have some good news. Your revised Consensus Statement article entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" has now been seen by the original referees #1 and #2, and their comments are included below. In light of their advice, I am delighted to say that we can now in principle offer to publish it,“ ….to Kareem and all colleagues, congratulations and thank you for your commitment towards Impact 32,3 Mit freundlichen Grüßen / Best regards, Juergen ------------------------------------------------------- Prof. Dr.-Ing. habil. Prof. h. c. Juergen Czarske Head of Laboratory of Measurement and Sensor Systems Director of Institute of Circuits and Systems Director of Competence Center Biomedical Computational Laser Systems (BIOLAS) TUD Dresden University of Technology Fakultät Elektrotechnik und Informationstechnik / Faculty of Electrical and Computer Engineering Institut für Grundlagen der Elektrotechnik und Elektronik / Institute of Circuits and Systems Professur für Mess- und Sensorsystemtechnik / Chair of Measurement and Sensor Systems Competence Center Biomedical Computational Laser Systems Co-opted Professor of Physics, Institute of Applied Physics, TU Dresden Adjunct Professor of Optical Sciences, Wyant College, University of Arizona 01062 Dresden, Germany Tel.: +49 (351) 463-34803 Fax: +49 (351) 463-37716 E-Mail: juergen.czarske(a)tu-dresden.de Internet: http://www.lasermetrology.de https://tu-dresden.de/ing/elektrotechnik/iee/mst https://tu-dresden.de/ing/elektrotechnik/iee/mst/ressourcen/dateien/profess… Fellow OPTICA/OSA (The Optical Society, Washington, DC, USA) Fellow SPIE (The International Society for Optics and Photonics, Bellingham, WA, USA) Fellow EOS (European Optical Society, Joensuu, Finland) Fellow IET (Institution of Engineering and Technology, London, UK) Fellow IoP (Institute of Physics, London, UK) Elected Vice President of ICO (International Commission for Optics, Palaiseau/Paris, France & Miami, USA) Symposium “20 years of Chair MST/Czarske Lab: From Biomedical to Quantum Systems (IYQ)”, 04 April 2025 SF: Conference Presentation Multicore fiber modified via ablation and thermal treatment for lensless endoscopic imaging 25 January 2025 • 2:25 PM - 2:40 PM PST | Moscone South, Room 212 (Level 2) <image001.png> Conference Presentation Endomicroscopy through a multicore fiber using a static multispectral hologram for wavefront shaping 26 January 2025 • 2:00 PM - 2:20 PM PST | Moscone South, Room 308 (Level 3) <image001.png> Conference Presentation Fiber Endoscopy Using Synthetic Wavelengths for 3D tissue imaging 26 January 2025 • 10:00 AM - 10:20 AM PST | Moscone South, Room 306 (Level 3) <image001.png> Conference Presentation Digital holography and physics-informed neural networks for mode decomposition of multimode fibers towards classical and quantum communication 29 January 2025 • 3:00 PM - 3:30 PM PST | Moscone West, Room 2006 (Level 2) <image001.png> Conference Presentation End-to-end brain cancer diagnosis using high-resolution fiber endoscopy with a learning-based digital twin 26 January 2025 • 11:00 AM - 11:20 AM PST | Moscone South, Room 203 (Level 2) <image001.png> Conference Presentation Computational 3D fiber endoscopy with end-to-end optimization by physics-informed deep learning 26 January 2025 • 9:40 AM - 10:00 AM PST | Moscone South, Room 306 (Level 3) <image001.png> Conference Presentation Excitation wavefront tracking and control of in vitro human induced cardiomyocytes using a digital holographic stimulation system 25 January 2025 • 5:00 PM - 5:20 PM PST | Moscone South, Room 155 (Upper Mezz) Von: Kareem Elsayad <kareem.elsayad(a)meduniwien.ac.at> Datum: Mittwoch, 26. Februar 2025 um 04:24 An: "consensus(a)biobrillouin.org" <consensus(a)biobrillouin.org> Betreff: [Consensus Statement] FW: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A Hi All, Just quick update I got & wanted to share 😊 Should be able to deal with this without your help -- only formatting stuff (but will contact you individually if/as needed). Will keep you posted, and I guess you will get some form of confirmation when uploaded again. Thanks again for being part of this & see you latest (hopefully) in Boston! All the best, Kareem From: <giampaolo.pitruzzello(a)nature.com> Reply to: <giampaolo.pitruzzello(a)nature.com> Date: Wednesday, 26. February 2025 at 03:30 To: <kareem.elsayad(a)meduniwien.ac.at> Subject: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A 25th February 2025 * Please ensure you delete the link to your author homepage in this e-mail if you wish to forward it to your co-authors. Dear Kareem, I have some good news. Your revised Consensus Statement article entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" has now been seen by the original referees #1 and #2, and their comments are included below. In light of their advice, I am delighted to say that we can now in principle offer to publish it, provided that you revise the paper to format it in accordance with our needs described below. Our format requirements are explained in full at www.nature.com/nphoton/authors/index.html. 1. Title. To avoid unwieldy titles, we ask that you use no more than 15 words, and no punctuation. I believe that the current title is sufficiently clear and concise and that no further changes are needed. 2. Headings. I think that the current headings are suitable and suggest no changes are made. 3. Abstract. The abstract should serve as a general introduction to the topic, underlining the importance and relevance of a particular area, and as a brief guide to the coverage of the Consensus Statement article. Because we hope that scientists in a wide range of research areas will be interested in our articles, the abstract should be as accessible as possible, explaining essential but specialised terms concisely. We encourage you to show your abstract to colleagues in other fields to uncover any problematic concepts. This paragraph must contain no more than 120 words and should not include references. I suggest the version below which has been edited for reasons of length and clarity: Brillouin Light Scattering (BLS) spectroscopy is a non-invasive, non-contact, label-free optical technique that can provide information on the mechanical properties of a material on the sub-micron scale. Over the last decade, BLS has seen increased applications in the life sciences, driven by the observed significance of mechanical properties in biological processes, the realization of more sensitive BLS spectrometers and the extension of BLS to an imaging modality. As with other spectroscopic techniques, BLS measurements not only detect signals characteristic of the investigated sample, but also of the experimental apparatus, and can be significantly affected by measurement conditions. Here, we report a consensus between researchers in the field. We aim to improve the comparability of BLS studies by providing reporting recommendations for the measured parameters and detailing common artifacts. Given that most BLS studies of biological matter are still at proof-of-concept stages and use different, often self-built, spectrometers, a consensus statement is particularly timely to ensure unified advancement. 4. Main text. Please take care to ensure that the length does not exceed 6000 words To ensure that a Consensus Statement article is likely to be accessible to as many readers as possible, it may be useful to ask a colleague from another discipline to read the manuscript before resubmitting it. ** Please ensure that all acronyms and symbols in equations are defined when first introduced. ** Please use UK English throughout. ** Please use a plain black font with no high highlighting or underlining. ** Please remove all figures from the main text and supply them as separate files. 5. Figures. A Consensus Statement typically contains 4-6 display items (figures, tables and boxes) and these should be supplied separately from the main text. *** Please ensure that all figures have scale bars as appropriate. *** Please ensure that all axes of graphs are labelled clearly and supplied with units. If your figures contain several parts, the parts should be labelled lower case a, b, and so on, and form a neat rectangle when assembled. For detailed instructions, please see our Guide for Authors at https://www.nature.com/documents/NRJs-guide-to-preparing-final-artwork.pdf If you have reproduced or adapted figure from other venues, please provide us full details of the figures so that we can approach the relevant authors for high-resolution files and the relevant publishers for figure permissions. The form can be found here: http://www.nature.com/documents/thirdpartyrights-table.doc If the figures come from your group, please provide us their high-resolution files. Below are some of the guidelines. For more details, please refer to the digital figure guidelines at the end of this email. Figure files must be supplied at an appropriate resolution for print publication. Colour: 300 dpi minimum; please convert all colour files into CMYK mode. Greyscale: 600 dpi minimum for black-and-white photographs. Line art: 1,200 dpi minimum for graphs and illustrations. Please do not scan laser printouts of figures and send them to us as digital files. The dot pattern on a laser print often creates a moire pattern when scanned. 6. Figure captions. Each caption should start with a brief introductory sentence to describe the figure as a whole, before going on to describe each panel of the figure (labelled a, b, c, etc.) in more detail, including any symbols that are used. The caption for each figure should not exceed 150 words. 7. References. ** As a guideline, a Consensus Statement allows up to ~ 100 references. ** Please check that your formatting is correct. Please note that Nature Photonics adopts the standard Nature referencing style, i.e. - All authors should be included in reference lists unless there are more than five, in which case only the first author should be given, followed by 'et al.'. Authors should be listed last name first, followed by a comma and initials of given names. There should be no spaces between initials. Article titles should be in Roman text and book titles in italics; the first word of the title is capitalized, the title written exactly as it appears in the work cited, ending with a full stop. Journal names are italicized and abbreviated (with full stops) according to common usage; please refer to Index Medicus for details. Volume numbers should appear in bold. Please correct the format of your references as necessary. References are numbered sequentially as they appear in the text, tables and figure legends. We only allow one publication is given for each reference number. Only papers that have been published or accepted by a named publication should appear in the numbered list; preprints of accepted papers in the reference list should be submitted with the manuscript. Meeting abstracts and submitted manuscripts should be mentioned in the text with a list of authors (or initials if any of the authors are co-authors of the present contribution). Authors should avoid excessive use of "unpublished results". Published conference abstracts and URLs for web sites should be cited parenthetically in the text, not in the reference list. Grant details and acknowledgements are not permitted as numbered references. Footnotes are not used. 8. Acknowledgements. These should appear after the references at the end of the manuscript. Please keep them brief; professional titles and affiliations are unnecessary. Grant numbers may be included. 9. Materials & Correspondence. Please include a statement naming the author to whom correspondence and requests for materials should be addressed. 10. Manuscript file format. *** When uploading the final version of your manuscript please be sure to include a MS Word .doc format of the main text (our production department handling Reviews/Perspectives/Consensus Statement manuscripts can not process LaTeX, .pdf etc). We will not send your revised paper for further review if, in the editors' judgement, the referees' comments on the present version have been fully addressed. If the revised paper is in Nature Photonics format, in accessible style and of appropriate length, we shall accept it for publication immediately. 11. Competing Interests In the interests of transparency, Nature and the Nature Portfolio journals now require authors of most article types to declare any financial and non-financial competing interest. Therefore, on behalf of all authors, we ask that you take particular care to declare any competing interests when submitting your Comment in the Manuscript Tracking System, under the “Detailed Information” tab of “Manuscript Information”. Please also add a competing interests declaration to your article file (if you do not have any competing interests, please include the statement “The authors declare no competing interests”). The competing interests statement will be published with the final article. For more information please see our Competing Interests policy page 12. ORCID Nature Photonics is committed to improving transparency in authorship. As part of our efforts in this direction, we are now requesting that all authors identified as ‘corresponding author’ create and link their Open Researcher and Contributor Identifier (ORCID) with their account on the Manuscript Tracking System (MTS) prior to acceptance. ORCID helps the scientific community achieve unambiguous attribution of all scholarly contributions. For more information please visit http://www.springernature.com/orcid For all corresponding authors listed on the manuscript, please follow the instructions in the link below to link your ORCID to your account on our MTS before submitting the final version of the manuscript. If you do not yet have an ORCID you will be able to create one in minutes. https://www.springernature.com/gp/researchers/orcid/orcid-for-nature-resear… IMPORTANT: All authors identified as ‘corresponding author’ on the manuscript must follow these instructions. Non-corresponding authors do not have to link their ORCIDs but are encouraged to do so. Please note that it will not be possible to add/modify ORCIDs at proof. Thus, if they wish to have their ORCID added to the paper they must also follow the above procedure prior to acceptance. To support ORCID's aims, we only allow a single ORCID identifier to be attached to one account. If you have any issues attaching an ORCID identifier to your MTS account, please contact the http://platformsupport.nature.com/"">Platform Support Helpdesk. 13. CONSORTIA AUTHORSHIP For papers containing one or more consortia, all members of the consortium who contributed to the paper must be listed in the paper (i.e., print/online PDF). If necessary, individual authors can be listed in both the main author list and as a member of a consortium listed at the end of the paper. When submitting your revised manuscript via the online submission system, the consortium name should be entered as an author, together with the contact details of a nominated consortium representative. See https://www.nature.com/authors/policies/authorship.html for our authorship policy and https://www.nature.com/documents/nr-consortia-formatting.pdf for further consortia formatting guidelines, which should be adhered to prior to acceptance. Before we can proceed with final acceptance of your manuscript, you will need to submit a final version of the revised manuscript text and all publication quality figures (if the figures are from your group), together with a point-by-point response to all of the referees' concerns, as well as our editorial requests. Please use the following link to do this: LINK I SHOULD DELETE * This URL links to your confidential homepage and associated information about manuscripts you may have submitted or be reviewing for us. If you wish to forward this e-mail to co-authors, please delete this link to your homepage first. Nature Photonics has now transitioned to a unified Rights Collection system which will allow our Author Services team to quickly and easily collect the rights and permissions required to publish your work. Once your paper is accepted, you will receive an email in approximately 10 business days providing you with a link to complete the grant of rights. Please note that you will not receive your proofs until the publishing agreement has been received through our system. If you have any questions please contact ASJournals(a)springernature.com. * Suggestions for cover illustrations, which should be provided as high resolution electronic files, are welcome. Please note that such pictures should be selected more for their aesthetic appeal than for their scientific content. As I am sure you will understand, we cannot make any promise as to whether any of your suggestions might be selected for the cover of Nature Photonics. Carefully following the guidelines outlined above, as well as those listed in the Nature Photonics Guide to Authors (www.nature.com/nphoton/authors/index.html) will eliminate any unnecessary delays in the processing of your manuscript once it is formally accepted. ** We hope to hear from you within three weeks; please let us know if the revision process is likely to take longer. In recognition of the time and expertise our reviewers provide to Nature Photonics’s editorial process, we would like to formally acknowledge their contribution to the external peer review of your manuscript entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials". For those reviewers who give their assent, we will be publishing their names alongside the published article. We will not be publishing any of the submitted peer review comments. And finally, you may be aware that Nature Photonics encourages the posting of submitted manuscripts on the preprint server, www.arxiv.org. We do, however, ask you to respect our policy on the posting of particular versions of the manuscript, summarized as follows: 1. You are welcome to post the original submitted version of the manuscript at any time. 2. The accepted version of the manuscript, following the review process, may only be posted 6 months after the paper is published in Nature Photonics. 3. The published version - copyedited and in Nature Photonics format - may not be posted in the arxiv or on authors' websites. Best wishes, Dr Giampaolo Pitruzzello Senior Editor Nature Photonics ***************************************************** Please see our Guide to Preparing Final Artwork here: https://www.nature.com/documents/NRJs-guide-to-preparing-final-artwork.pdf for detailed instructions of how to format your figures. Reviewers’ Comments: -------------------- Reviewer #1 (Remarks to the Author): The authors have thoroughly addressed all my concerns, and I have no additional comments. I fully support the publication of this manuscript without delay. Reviewer #2 (Remarks to the Author): The authors addressed my previous comments satisfactorily, and I recommend that the manuscript be accepted for publication in its current form. ***************************************************** This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS Confidentiality Statement: This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com . Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html Privacy Policy | Update Profile

2 1

Re: Consensus Statement (revision to be submitted)
by Kareem Elsayad Jan. 13, 2025

Jan. 13, 2025

Hi All, just a quick update that we re-submitted manuscript with all your corrections. Uploaded files to google drive under sub-folder “submitted” in previous link that you should all have access to. Let’s see what they say, but think we are prob good, and can call it a wrap (& get back to more fun fundamental and applied stuff 😊) All the best, Kareem From: Kareem Elsayad <kareem.elsayad(a)meduniwien.ac.at> Date: Thursday, 9. January 2025 at 13:47 To: "consensus(a)biobrillouin.org" <consensus(a)biobrillouin.org> Subject: Consensus Statement (revision to be submitted) Dear All, Firstly, I hope you all had a good start to the new year! We worked through the revision for the consensus statement and would like to send reply to reviewers with amended text by beginning of next week. As mentioned in last email, the reviews were all very nice and straightforward to address. The files can all be found here: https://drive.google.com/drive/folders/1mpQcbs1PCA1XiKrRpwskSeKMCxFXBaZu?us… Please comment on any desired modifications etc. by Monday. Thanks and all the best, Kareem

2 1

Re: Consensus Statement (revision to be submitted)
by Czarske, Juergen Jan. 13, 2025

Jan. 13, 2025

Fingers crossed. Appreciate the great commitment Mit freundlichen Grüßen / Best regards, Juergen ------------------------------------------------------- Prof. Dr.-Ing. habil. Jürgen Czarske Head of Laboratory of Measurement and Sensor System Technique Director of Institute of Circuits and Systems Director of Competence Center Biomedical Computational Laser Systems (BIOLAS) TUD - Dresden University of Technology Fakultät Elektrotechnik und Informationstechnik / Faculty of Electrical and Computer Engineering Institut für Grundlagen der Elektrotechnik und Elektronik / Institute of Circuits and Systems Professur für Mess- und Sensorsystemtechnik / Chair of Measurement and Sensor Systems Competence Center Biomedical Computational Laser Systems Co-opted Professor of Physics, Institute of Applied Physics, TU Dresden 01062 Dresden, Germany Tel.: +49 (351) 463-34803 Fax: +49 (351) 463-37716 E-Mail: juergen.czarske(a)tu-dresden.de Internet: http://www.lasermetrology.de https://tu-dresden.de/ing/elektrotechnik/iee/mst https://tu-dresden.de/ing/elektrotechnik/iee/mst/ressourcen/dateien/profess… Fellow OPTICA/OSA (The Optical Society, Washington, DC, USA) Fellow SPIE (The International Society for Optics and Photonics, Bellingham, WA, USA) Fellow EOS (European Optical Society, Joensuu, Finland) Fellow IET (Institution of Engineering and Technology, London, UK) Fellow IoP (Institute of Physics, London, UK) Elected Vice President of ICO (International Commission for Optics, Palaiseau/Paris, France & Miami, USA) Von: Kareem Elsayad <kareem.elsayad(a)meduniwien.ac.at> Datum: Montag, 13. Januar 2025 um 03:57 An: "consensus(a)biobrillouin.org" <consensus(a)biobrillouin.org> Betreff: [Consensus Statement] Re: Consensus Statement (revision to be submitted) Hi All, just a quick update that we re-submitted manuscript with all your corrections. Uploaded files to google drive under sub-folder “submitted” in previous link that you should all have access to. Let’s see what they say, but think we are prob good, and can call it a wrap (& get back to more fun fundamental and applied stuff 😊) All the best, Kareem From: Kareem Elsayad <kareem.elsayad(a)meduniwien.ac.at> Date: Thursday, 9. January 2025 at 13:47 To: "consensus(a)biobrillouin.org" <consensus(a)biobrillouin.org> Subject: Consensus Statement (revision to be submitted) Dear All, Firstly, I hope you all had a good start to the new year! We worked through the revision for the consensus statement and would like to send reply to reviewers with amended text by beginning of next week. As mentioned in last email, the reviews were all very nice and straightforward to address. The files can all be found here: https://drive.google.com/drive/folders/1mpQcbs1PCA1XiKrRpwskSeKMCxFXBaZu?us… Please comment on any desired modifications etc. by Monday. Thanks and all the best, Kareem

2 1